331 related articles for article (PubMed ID: 21555464)
21. Calcium influx and postsynaptic proteins coordinate the dendritic filopodium-spine transition.
Hu HT; Hsueh YP
Dev Neurobiol; 2014 Oct; 74(10):1011-29. PubMed ID: 24753440
[TBL] [Abstract][Full Text] [Related]
22. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
Pan ZG; An XS
Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
[TBL] [Abstract][Full Text] [Related]
23. Context-Specific Stress Causes Compartmentalized SARM1 Activation and Local Degeneration in Cortical Neurons.
Hinz FI; Villegas CLM; Roberts JT; Yao H; Gaddam S; Delwig A; Green SA; Fredrickson C; Adrian M; Asuncion RR; Cheung TK; Hayne M; Hackos DH; Rose CM; Richmond D; Hoogenraad CC
J Neurosci; 2024 Jun; 44(24):. PubMed ID: 38692735
[TBL] [Abstract][Full Text] [Related]
24. Autophagy protein ULK1 interacts with and regulates SARM1 during axonal injury.
Choi HMC; Li Y; Suraj D; Hsia RC; Sarkar C; Wu J; Lipinski MM
Proc Natl Acad Sci U S A; 2022 Nov; 119(47):e2203824119. PubMed ID: 36375051
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy.
Bosanac T; Hughes RO; Engber T; Devraj R; Brearley A; Danker K; Young K; Kopatz J; Hermann M; Berthemy A; Boyce S; Bentley J; Krauss R
Brain; 2021 Nov; 144(10):3226-3238. PubMed ID: 33964142
[TBL] [Abstract][Full Text] [Related]
26. Sarm1 loss reduces axonal damage and improves cognitive outcome after repetitive mild closed head injury.
Maynard ME; Redell JB; Zhao J; Hood KN; Vita SM; Kobori N; Dash PK
Exp Neurol; 2020 May; 327():113207. PubMed ID: 31962129
[TBL] [Abstract][Full Text] [Related]
27. cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons.
Sasaki Y; Engber TM; Hughes RO; Figley MD; Wu T; Bosanac T; Devraj R; Milbrandt J; Krauss R; DiAntonio A
Exp Neurol; 2020 Jul; 329():113252. PubMed ID: 32087251
[TBL] [Abstract][Full Text] [Related]
28. Genetic inactivation of SARM1 axon degeneration pathway improves outcome trajectory after experimental traumatic brain injury based on pathological, radiological, and functional measures.
Bradshaw DV; Knutsen AK; Korotcov A; Sullivan GM; Radomski KL; Dardzinski BJ; Zi X; McDaniel DP; Armstrong RC
Acta Neuropathol Commun; 2021 May; 9(1):89. PubMed ID: 34001261
[TBL] [Abstract][Full Text] [Related]
29. The microRNAs Let7c and miR21 are recognized by neuronal Toll-like receptor 7 to restrict dendritic growth of neurons.
Liu HY; Huang CM; Hung YF; Hsueh YP
Exp Neurol; 2015 Jul; 269():202-12. PubMed ID: 25917529
[TBL] [Abstract][Full Text] [Related]
30. Passenger Mutations Confound Phenotypes of SARM1-Deficient Mice.
Uccellini MB; Bardina SV; Sánchez-Aparicio MT; White KM; Hou YJ; Lim JK; García-Sastre A
Cell Rep; 2020 Apr; 31(1):107498. PubMed ID: 32268088
[TBL] [Abstract][Full Text] [Related]
31. Neurotoxins subvert the allosteric activation mechanism of SARM1 to induce neuronal loss.
Wu T; Zhu J; Strickland A; Ko KW; Sasaki Y; Dingwall CB; Yamada Y; Figley MD; Mao X; Neiner A; Bloom AJ; DiAntonio A; Milbrandt J
Cell Rep; 2021 Oct; 37(3):109872. PubMed ID: 34686345
[TBL] [Abstract][Full Text] [Related]
32. p39-associated Cdk5 activity regulates dendritic morphogenesis.
Ouyang L; Chen Y; Wang Y; Chen Y; Fu AKY; Fu WY; Ip NY
Sci Rep; 2020 Oct; 10(1):18746. PubMed ID: 33127972
[TBL] [Abstract][Full Text] [Related]
33. Multiple domain interfaces mediate SARM1 autoinhibition.
Shen C; Vohra M; Zhang P; Mao X; Figley MD; Zhu J; Sasaki Y; Wu H; DiAntonio A; Milbrandt J
Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33468661
[TBL] [Abstract][Full Text] [Related]
34. Attenuated traumatic axonal injury and improved functional outcome after traumatic brain injury in mice lacking Sarm1.
Henninger N; Bouley J; Sikoglu EM; An J; Moore CM; King JA; Bowser R; Freeman MR; Brown RH
Brain; 2016 Apr; 139(Pt 4):1094-105. PubMed ID: 26912636
[TBL] [Abstract][Full Text] [Related]
35. Sarm1-mediated axon degeneration requires both SAM and TIR interactions.
Gerdts J; Summers DW; Sasaki Y; DiAntonio A; Milbrandt J
J Neurosci; 2013 Aug; 33(33):13569-80. PubMed ID: 23946415
[TBL] [Abstract][Full Text] [Related]
36. TIR-1/SARM1 inhibits axon regeneration and promotes axon degeneration.
Czech VL; O'Connor LC; Philippon B; Norman E; Byrne AB
Elife; 2023 Apr; 12():. PubMed ID: 37083456
[TBL] [Abstract][Full Text] [Related]
37. CRISPR/Cas9-mediated SARM1 knockout and epitope-tagged mice reveal that SARM1 does not regulate nuclear transcription, but is expressed in macrophages.
Doran CG; Sugisawa R; Carty M; Roche F; Fergus C; Hokamp K; Kelly VP; Bowie AG
J Biol Chem; 2021 Dec; 297(6):101417. PubMed ID: 34793837
[TBL] [Abstract][Full Text] [Related]
38. Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease.
Peters OM; Weiss A; Metterville J; Song L; Logan R; Smith GA; Schwarzschild MA; Mueller C; Brown RH; Freeman M
Neurobiol Dis; 2021 Jul; 155():105368. PubMed ID: 33892050
[TBL] [Abstract][Full Text] [Related]
39. SARM1 is required in human derived sensory neurons for injury-induced and neurotoxic axon degeneration.
Chen YH; Sasaki Y; DiAntonio A; Milbrandt J
Exp Neurol; 2021 May; 339():113636. PubMed ID: 33548217
[TBL] [Abstract][Full Text] [Related]
40. Permeant fluorescent probes visualize the activation of SARM1 and uncover an anti-neurodegenerative drug candidate.
Li WH; Huang K; Cai Y; Wang QW; Zhu WJ; Hou YN; Wang S; Cao S; Zhao ZY; Xie XJ; Du Y; Lee CS; Lee HC; Zhang H; Zhao YJ
Elife; 2021 May; 10():. PubMed ID: 33944777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]